This refers to tumors that grow in the choroid, the blood vessel layer at the back of the eye. These are usually found in adults and can sometimes cause vision problems.
Every report comes from a Lived member, sent anonymously.
Have you had Brachytherapy for Choroid Tumors?
Choroid tumors are growths in the choroid, the layer of blood vessels that lies between the retina (the light-sensing lining at the back of the eye) and the eye's tough white outer wall. The choroid supplies oxygen and nutrients to the retina, and its rich blood flow is one reason several quite different kinds of tumor can form or settle there. The label covers growths that behave very differently. A choroidal nevus is a flat, freckle-like patch of pigment cells; it is common, usually harmless and often found by chance. Choroidal melanoma is a cancer of those pigment cells. It is rare, but it is the most common cancer that starts inside the eye in adults, and it matters because it can spread to other organs. Cancers that begin elsewhere, most often in the breast or lung, can also travel through the bloodstream to the choroid; these choroidal metastases are the most common cancerous tumors inside the adult eye. A choroidal hemangioma is a noncancerous cluster of blood vessels that matters mainly because it can leak fluid under the retina and blur vision. Many choroid tumors cause no symptoms at first and are found during a routine dilated eye exam. When symptoms do appear, they are usually blurred or distorted vision, new floaters, flashes of light or a shadow over part of the visual field, often because fluid has collected beneath the retina.
The cause depends on the type of tumor. Choroidal melanoma develops when pigment cells in the choroid acquire genetic changes that let them grow out of control. It is diagnosed most often in older adults, with rates rising steadily to a peak around age 70. It is more common in people who are White, have fair skin that burns easily, or have blue, green or other light-colored eyes. Studies of sunlight exposure have found only weak or inconsistent links, so sun exposure is not an established cause. A nevus can occasionally turn into melanoma, which is why a nevus with worrying features is photographed and rechecked, but most nevi are small and never become cancer. Choroidal metastases occur in people with cancer elsewhere in the body. Breast cancer is the most common source in women and lung cancer in men. Sometimes the eye tumor is the first sign of a cancer that had not yet been diagnosed. A circumscribed (single, well-defined) choroidal hemangioma is present from birth and has no known cause; it usually comes to attention in adulthood, when it begins to leak. A more widespread form, called diffuse choroidal hemangioma, occurs in people with Sturge-Weber syndrome, a congenital condition that affects blood vessels of the skin, brain and eye.
Most choroid tumors are diagnosed by an eye specialist, often an ocular oncologist (an ophthalmologist who specializes in eye tumors), from a careful examination rather than a tissue sample. After drops widen (dilate) the pupil, the doctor examines the back of the eye and takes photographs that serve as a baseline for later comparison. An ultrasound of the eye, using a small probe placed on the numbed eye, measures how thick the tumor is and shows its internal pattern. Thickness and width matter twice over: they help tell one kind of tumor from another, and they guide treatment. Optical coherence tomography (OCT), a light-based scan, shows fluid under the retina, and angiography, in which a dye injected into an arm vein is photographed as it flows through the eye's blood vessels, helps distinguish melanoma from a hemangioma or a metastasis. A small melanoma can look exactly like a nevus. When a spot is borderline, the usual approach is to repeat the photographs and ultrasound after a few months; growth is one of the strongest signs that a spot is melanoma. Unlike most cancers, choroidal melanoma rarely needs a biopsy to be diagnosed. A needle biopsy may be done when the diagnosis is uncertain or to test the tumor's genes, which helps estimate how likely the melanoma is to spread. It carries a small risk of retinal detachment, which can be repaired surgically. If melanoma is confirmed, blood tests of liver function and imaging of the liver, and sometimes the chest, check whether it has spread. If the eye tumor looks like a metastasis, scans of the body look for the original cancer and for other sites of spread, including the brain.
Treatment depends on what the tumor is, its size and position in the eye, and the person's overall health. A nevus needs no treatment, only periodic photographs and exams to confirm it is stable. For choroidal melanoma, the aims are to control the tumor, keep the eye and as much sight as possible, and reduce the chance of spread. A small tumor that is not clearly growing may be watched closely. The most common eye-sparing treatment is plaque brachytherapy: a small disc carrying radioactive seeds is stitched to the outside wall of the eye over the tumor, left for several days, then removed. Proton beam radiation, aimed from outside the eye, is an alternative at specialized centers, and laser or heat treatment is sometimes added for small tumors. In a large trial of medium-sized choroidal melanomas, plaque radiation and removal of the eye led to the same survival, so most people with medium tumors can keep the eye. The trade-off is vision: 85 percent of people treated with plaque radiation kept the eye for at least five years, but only about 37 percent still saw better than 20/200 (the large letter at the top of a standard eye chart) with it at five years. Removing the eye (enucleation) is used when a tumor is too large for eye-sparing treatment, has grown into the optic nerve, or has caused high pressure inside the eye. An artificial eye matched in size and color to the other eye is fitted afterward. Treating melanoma that has spread remains difficult. Tebentafusp (Kimmtrak), an immunotherapy given by weekly infusion, is approved for adults whose melanoma has spread or cannot be removed and who carry a particular inherited immune marker, a human leukocyte antigen (HLA) type called HLA-A*02:01, identified by a lab test. In its main trial, people lived a median of about 22 months with it compared with 16 months with other drugs. It can trigger a serious inflammatory reaction called cytokine release syndrome, so each of the first three infusions is followed by at least 16 hours of monitoring. Surgery for limited spread and clinical trials are other options. For choroidal metastases, treatment is usually led by the oncologist treating the original cancer. Chemotherapy, hormone therapy, immunotherapy or targeted drugs given for that cancer often shrink the eye tumor as well. A single eye tumor in someone otherwise well can be treated directly with radiation or light-based therapy to protect vision, while observation may be reasonable when overall health is poor. A circumscribed choroidal hemangioma that causes no symptoms is often simply watched. When it leaks fluid that blurs vision, the usual treatment is photodynamic therapy: a light-sensitive drug, verteporfin, is injected into a vein, and a low-energy laser aimed at the tumor activates it to close off the leaking vessels. It typically shrinks the tumor and dries the fluid, though the tumor can regrow after a few years and need further treatment.
The outlook depends far more on the type of tumor than on the label. Most nevi stay unchanged for life and need only regular checks with photographs, which become less frequent once a nevus has proved stable. With choroidal melanoma, the course in the eye and the course in the rest of the body run separately. Many people keep the treated eye, but sight in that eye often declines gradually over the following years, and people in the trial reported growing difficulty with vision-based tasks over time. Tumors close to the center of vision or to the optic nerve tend to cost more sight, as do larger and thicker tumors. The larger concern is spread, which can appear years after the eye is treated and is usually found first in the liver. In the large trial of medium-sized tumors, about 13 percent of people had died of melanoma that spread by five years and about 21 percent by ten years, whichever treatment they received. Tumor size and genetic findings shift that risk up or down for an individual, so follow-up typically includes eye exams to confirm the tumor is controlled and regular liver imaging or blood tests for many years. When a choroid tumor is a metastasis, it signals that the original cancer has spread. The overall outlook depends mainly on that cancer and how it responds to treatment, and eye treatment focuses on protecting sight and comfort. Hemangiomas do not spread. Vision depends on whether leaking fluid reaches the center of the retina, and follow-up visits watch for fluid returning after treatment.
Arrange an eye exam if you notice blurred or distorted vision, or floaters or flashes that do not go away. If you have been told you have a choroidal nevus, keep the scheduled checks, because growth is what changes the plan, and a spot that has not been rechecked cannot be compared. See an eye doctor the same day for a sudden burst of new floaters or flashes, or a curtain or shadow spreading across your vision. These can signal a retinal detachment, which can cause permanent vision loss if it is not treated promptly. After treatment for melanoma, contact your care team about worsening vision or new pain in the treated eye, and keep surveillance scans even when you feel well.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Choroid Tumors is like, what's helped you, or ask the community a question.